Daewoong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,129,811	1,454,393	1,343,932	1,754,469	1,638,243	1,775,845
Market Cap Growth	36.61%	8.22%	-23.40%	7.09%	-7.75%	25.14%
Enterprise Value	2,873,544	2,099,040	1,735,899	2,148,696	2,022,062	2,205,804
Last Close Price	185100.00	125964.64	115832.21	156366.58	145448.14	161495.41
PE Ratio	22.86	58.80	11.04	41.54	66.85	139.25
Forward PE	13.35	14.39	14.77	22.77	41.35	41.35
PS Ratio	1.38	1.02	0.98	1.37	1.42	1.68
PB Ratio	2.05	1.51	1.43	2.37	2.35	2.55
P/TBV Ratio	4.19	2.24	2.15	3.79	3.83	4.26
P/FCF Ratio	-	-	50.39	33.11	150.21	23.84
P/OCF Ratio	16.20	28.25	9.88	14.84	40.96	17.59
PEG Ratio	0.13	1.07	0.78	0.39	0.24	0.24
EV/Sales Ratio	1.86	1.48	1.26	1.68	1.75	2.09
EV/EBITDA Ratio	14.06	10.81	10.53	15.86	15.60	38.12
EV/EBIT Ratio	18.67	14.45	14.33	22.43	22.79	129.91
EV/FCF Ratio	-151.12	-	65.09	40.55	185.40	29.61
Debt / Equity Ratio	0.76	0.68	0.47	0.60	0.64	0.64
Debt / EBITDA Ratio	3.31	3.34	2.68	3.30	3.44	7.70
Debt / FCF Ratio	-	-	16.55	8.43	40.87	5.98
Net Debt / Equity Ratio	0.56	0.55	0.32	0.41	0.39	0.39
Net Debt / EBITDA Ratio	2.44	2.74	1.84	2.26	2.10	4.64
Net Debt / FCF Ratio	-30.73	-5.14	11.38	5.78	24.94	3.61
Asset Turnover	0.74	0.76	0.83	0.86	0.83	0.81
Inventory Turnover	2.65	2.77	3.06	3.39	3.54	3.47
Quick Ratio	0.66	0.55	0.47	0.68	0.72	0.99
Current Ratio	1.22	1.03	0.86	1.16	1.13	1.62
Return on Equity (ROE)	9.62%	2.45%	14.27%	5.44%	4.32%	3.63%
Return on Assets (ROA)	5.66%	4.84%	4.54%	4.03%	3.99%	0.81%
Return on Invested Capital (ROIC)	10.08%	4.38%	10.40%	9.50%	9.18%	1.82%
Return on Capital Employed (ROCE)	11.80%	10.50%	11.00%	8.80%	9.30%	1.60%
Earnings Yield	4.38%	1.70%	9.06%	2.41%	1.50%	0.72%
FCF Yield	-0.89%	-7.13%	1.98%	3.02%	0.67%	4.20%
Dividend Yield	0.31%	0.48%	-	-	-	-
Payout Ratio	8.66%	31.30%	5.98%	19.10%	26.35%	48.56%
Buyback Yield / Dilution	-0.01%	-0.71%	-3.21%	-0.59%	-3.21%	-3.31%
Total Shareholder Return	0.30%	-0.24%	-3.21%	-0.59%	-3.21%	-3.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.